MedPath

Patient-reported outcomes in the treatment of oncological patients - A multicentred pilot study to select appropriate assessment instruments

Conditions
C00-D48
Neoplasms
Registration Number
DRKS00005337
Lead Sponsor
Wilhelm-Roux-Förderprogramm der Medizinischen Fakultät der Martin-Luther-Universität Halle-Wittenberg, Prodekanat Forschung
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
71
Inclusion Criteria

Cancer patients, aged >18 Years, heterogenious diagnoses, undergoing in and/ or out-patient treatment who gave written informed consent.

Exclusion Criteria

non-sufficient understanding of the German language, cognitive impairments (e.g. dementia) or not able to give informed consent.

Study & Design

Study Type
observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
A modular assessment tool that fulfils the requirements of both patients and practitioners to facilitate supportive therapy and symptom management of oncologic patients.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath